The DOI matches its Crossref record.
European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)
Abstract
Guidelines aim to present all the relevant evidence on a particular issue in order to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic procedure. They should be helpful in everyday clinical decision-making. A great number of guidelines have been issued in recent years by different organizations-European Society of Cardiology (ESC), American Heart Association (AHA), American College of Cardiology (ACC), and other related societies. By means of links to web sites of National Societies several hundred guidelines are available. This profusion can put at stake the authority and validity of guidelines, which can only be guaranteed if they have been developed by an unquestionable decision-making process. This is one of the reasons why the ESC and others have issued recommendations for formulating and issuing guidelines. In spite of the fact that standards for issuing good quality guidelines are well defined, recent surveys of guidelines published in peer-reviewed journals between 1985 and 1998 have shown that methodological standards were not complied with in the vast majority of cases. It is therefore of great importance that guidelines and recommendations are presented in formats that are easily interpreted. Subsequently, their implementation programmes must also be well conducted. Attempts have been made to determine whether guidelines improve the quality of clinical practice and the utilization of health resources. In addition, the legal implications of medical guidelines have been discussed and examined, resulting in position documents, which have been published by a specific Task Force.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We used the Copenhagen risk score, which is based on data from two large epidemiological studies in the Copenhagen area 16 and is recommended by the European Society of Cardiology for screening of cardiovascular risk 29 .”
Citations
Cited by
Sorted by citations
Items 901–999 of 999
Can a Statin Neutralize the Cardiovascular Risk of Unhealthy Dietary Choices?
Ferenczi, E. A., Asaria, P., Hughes, A. D., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.03.077 · Cited by 20
Martens, E. J., Smith, O. R. F., & Denollet, J. (2007) · Annals of Behavioral Medicine · doi:10.1007/bf02879924 · Cited by 20
Murray, J., Saxena, S. K., Millett, C. J., Ćurčin, V., de Lusignan, S., & Majeed, A. (2010) · Family Practice · doi:10.1093/fampra/cmq030 · Cited by 20
Okechukwu, I., Bennett, K., & Feely, J. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02621.x · Cited by 20
McCluskey, S., Baker, D., Percy, D. F., et al. (2007) · Journal of Public Health · doi:10.1093/pubmed/fdm045 · Cited by 20
Should All Diabetic Patients Be Treated With a Statin?
Kamari, Y., Bitzur, R., Cohen, H., Shaish, A., & Harats, D. (2009) · Diabetes Care · doi:10.2337/dc09-s344 · Cited by 22
The European Network on Psychosomatic Medicine (ENPM) – history and future directions
Deter, H., Orth‐Gomér, K., Wasilewski, B., et al. (2017) · BioPsychoSocial Medicine · doi:10.1186/s13030-016-0086-0 · Cited by 20
Vilaubí, J. M. P., Orozco‐Beltrán, D., Gonçalves, A. Q., Cumplido, D. R., Martín, C. A., López‐Pineda, A., Gil-Guillén, V. F., Quesada, J. A., & Carratalá‐Munuera, C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15061233 · Cited by 20
Rački, S., Zaputović, L., Vujičić, B., et al. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.05.015 · Cited by 20
The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study
Diamantopoulos, E. J., Athyros, V. G., Yfanti, G., Migdalis, E. N., Elisaf, M., Vardas, P. E., Manolis, A. S., Karamitsos, D. T., Ganotakis, E. S., Hatseras, D., et al. (2005) · Angiology · doi:10.1177/000331970505600611 · Cited by 20
Refocusing On Use of Cholesteryl Ester Transfer Protein Inhibitors
Kastelein, J. J. P. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.08.013 · Cited by 20
Lipids for Psychiatrists - an overview
Young, I. S. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105058374 · Cited by 20
Esteban-Salán, M., Aguilar-Doreste, J. A., Arranz-Peña, M. L., Juvé-Cuxart, S., Gich, I. J., Zapico‐Muñiz, E., & Ordóñez‐Llanos, J. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.07.014 · Cited by 20
Utilization of Statins in Reducing Comorbidities of Diabetes Mellitus: A Systematic Review
Maqbool, M., & Gani, I. (2018) · Journal of Pharmacy Practice and Community Medicine · doi:10.5530/jppcm.2018.4.46 · Cited by 25
Sepanlou, S. G., Malekzadeh, R., Poustchi, H., Sharafkhah, M., Ghodsi, S., Malekzadeh, F., Etemadi, A., Pourshams, A., Pharoah, P. D. P., Abnet, C. C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126779 · Cited by 21
Hou, P.-F., Deng, R., Guo, J., Chen, W., Li, X., & Yu, H. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03234-6 · Cited by 19
The Renin–Angiotensin System and Bone
Tamargo, J. L., Caballero, R., & Delpón, E. (2015) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-015-9189-6 · Cited by 18
dos Reis, R. P., Giacovelli, G., Girolami, F., André, R., Bonazzi, A., & Rovati, L. C. (2011) · The Open Rheumatology Journal · doi:10.2174/1874312901105010069 · Cited by 19
The under-use of statin in type 2 diabetic patients attending diabetic clinics in Italy
Avogaro, A., Guida, P., Giorda, C. B., Mannucci, E., Medea, G., Comaschi, M., Velussi, M., Armienti, G., & Zucchetti, R. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.12.001 · Cited by 19
Kovács, K. R., Bajkó, Z., Szekeres, C. C., Csapó, K., Oláh, L., Magyar, M. T., Molnár, S., Czuriga, D., Kardos, L., Burainé, A. B., et al. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.04.007 · Cited by 20
Carotenoid deficiency in chronic pancreatitis: the effect of an increase in tomato consumption
Quilliot, D., Forbes, A., Dubois, F., et al. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.232 · Cited by 19
Kardiologische Diagnostik nach zerebraler Ischämie
Laufs, U., Hoppe, U. C., Rosenkranz, S., Kirchhof, P. F., Böhm, M., Diener, H., Endres, M., Grond, M., Hacke, W., Meinertz, T., et al. (2010) · Der Nervenarzt · doi:10.1007/s00115-009-2901-3 · Cited by 18
Looking for prognostic information in the ST-T segment—is it really worth it?
Macfarlane, P. W., & Norrie, J. D. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2004.08.059 · Cited by 19
Gender Disparities in the Awareness and Control of Hypertension
Alsuwaida, A., & Alghonaim, M. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531857 · Cited by 19
Cowie, M. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2005.00601.x · Cited by 19
Cardiovascular protection by anti-inflammatory statin therapy
Howard-Alpe, G. M., Foëx, P., & Biccard, B. M. (2008) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2007.08.001 · Cited by 19
Price, H. C., Tucker, L., Griffin, S. J., & Holman, R. R. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-21 · Cited by 19
Multislice Computer Tomography for Detection of Coronary Artery Disease
Ropers, D. (2006) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2006.00200.x · Cited by 19
The benefits of marine omega-3s for preventing arrhythmias
DiNicolantonio, J. J., & O’Keefe, J. H. (2020) · Open Heart · doi:10.1136/openhrt-2018-000904 · Cited by 19
Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision
Trifirò, G., Alacqua, M., Corrao, S., Moretti, S., Tari, D. U., Galdo, M., UVEC Group, Caputi, A. P., & Arcoraci, V. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0459-1 · Cited by 18
Diego, P. G., Moreno‐Iribas, C., Guembe, M. J., Viñes, J. J., & Vila, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)72070-6 · Cited by 18
Mercury Exposure as a Function of Fish Consumption in Two Asian Communities in Coastal Virginia, USA
Xu, X., & Newman, M. C. (2014) · Archives of Environmental Contamination and Toxicology · doi:10.1007/s00244-014-0102-y · Cited by 18
“X. Xu (&) M. C. Newman Virginia Institute of Marine Science, College of William & Mary, P.O. Box 1346, Gloucester Point, VA 23062, USA e-mail: rain06012007@gmail.com Oken et al. 2005, 2008; De Backer et al. 2003; Priori et al. 2003; Smith et al. 2006).”
Physicians' Perceived Barriers to Promoting Smoking Cessation
Berlin, I. (2008) · The Journal of Smoking Cessation · doi:10.1375/jsc.3.2.92 · Cited by 18
Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?
Volpe, M. (2011) · QJM · doi:10.1093/qjmed/hcr190 · Cited by 19
Porta, B., Baldassarre, D., Camera, M., et al. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.008 · Cited by 18
Pisa, P., Kruger, A., Vorster, H., Margetts, B. M., & Loots, D. T. (2010) · South African Journal of Clinical Nutrition · doi:10.1080/16070658.2010.11734299 · Cited by 19
Wang, W., Ma, L., Zhang, Y., Deng, Q., Liu, M., & Liu, L. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.45 · Cited by 18
Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus
Anderson, J. E., Wright, E. E., & Shaefer, C. F. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0211-x · Cited by 19
Chung, N., Park, H., Park, M.-Y., Hwang, Y.-Y., Lee, C.-H., Han, J.-S., So, J.-M., Kim, J., Park, J., & Lim, K. (2017) · Physical Activity and Nutrition · doi:10.20463/jenb.2017.0026 · Cited by 18
MOHSIN, A., & Faust, O. (2019) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519419400098 · Cited by 18
Palmou‐Fontana, N., Martínez-López, D., Corrales, A., et al. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190729 · Cited by 18
Cardiovascular Disease in Juvenile Idiopathic Arthritis
Arsenaki, E., Georgakopoulos, P., Mitropoulou, P., Koutli, E., Thomas, Κ., Charakida, M., & Georgiopoulos, G. A. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200408121307 · Cited by 18
Sequí‐Domínguez, I., Cavero‐Redondo, I., Álvarez‐Bueno, C., Saz‐Lara, A., Mesas, A. E., & Martínez‐Vizcaíno, V. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002754 · Cited by 18
“Arterial stiffness is an established marker of subclinical CVD and a useful tool for cardiovascular risk stratification [11].”
Ohtera, S., Kato, G., Ueshima, H., Mori, Y., Nakatani, Y., Ozasa, N., Nakayama, T., & Kuroda, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-99516-1 · Cited by 19
Cardiological evaluation after cerebral ischaemia
Laufs, U., Hoppe, U. C., Rosenkranz, S., Kirchhof, P. F., Böhm, M., Diener, H., Endres, M., Grond, M., Hacke, W., Meinertz, T., et al. (2010) · Clinical Research in Cardiology · doi:10.1007/s00392-010-0200-4 · Cited by 18
Wanderley, F. A. C., de Oliveira, J. J. F., Mota, J. A. P. S., & Carvalho, J. (2010) · Archives of Exercise in Health and Disease · doi:10.5628/aehd.v1i2.87 · Cited by 18
Effective care of patients with type 2 diabetes and dyslipidemia: A nurse's perspective
Adiseshiah, M. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.03.017 · Cited by 19
Panagiotakos, D. B., & Stavrinos, V. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.309 · Cited by 18
“Based on these models risk charts have been incorporated into guidelines for the prevention of cardiovascular disease and for treating risk factors (NCEP 2002; BCS et al 2003; De Backer et al 2003).”
Niemiec, P., Żak, I., & Wita, K. (2008) · European Journal of Epidemiology · doi:10.1007/s10654-008-9241-7 · Cited by 18
Épidémiologie et facteurs de risque d' ostéoporose
Dargent‐Molina, P. (2004) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(04)80049-3 · Cited by 17
Alkerwi, A., Sauvageot, N., Pagny, S., Beissel, J., Delagardelle, C., & Lair, M. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-864 · Cited by 18
Fan, M., Raitakari, O. T., Kähönen, M. A. P., Juonala, M., Hutri‐Kähönen, N., Marniemi, J., Rontu, R., Pörsti, I. H., Viikari, J. S. A., & Lehtimäki, T. J. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32810bfe58 · Cited by 18
Beune, E., Haafkens, J. A., & Bindels, P. (2010) · Patient Education and Counseling · doi:10.1016/j.pec.2010.02.015 · Cited by 18
Omega-3 fatty acids for the treatment of elevated triglycerides
Maki, K. C., Dicklin, M. R., Lawless, A. L., & Reeves, M. P. (2009) · Clinical Lipidology · doi:10.2217/clp.09.34 · Cited by 18
Vogiatzi, K., Apostolakis, S. Z., Voudris, V. A., et al. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0338-y · Cited by 18
Torque control of an active elastic transfemoral prosthesis via quasi-static modelling
Heins, S., Flynn, L., Geeroms, J., Lefeber, D., & Ronsse, R. (2018) · Robotics and Autonomous Systems · doi:10.1016/j.robot.2018.05.015 · Cited by 18
Dietary nitrate consumption and risk of CHD in women from the Nurses’ Health Study
Jackson, J. K., Zong, G., MacDonald‐Wicks, L. K., Patterson, A. J., Willett, W. C., Rimm, E. B., Manson, J. E., & McEvoy, M. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519000096 · Cited by 18
Lipid Management and Cholesterol Goal Attainment in Norway
Ose, L., Skjeldestad, F. E., Bakken, I. J., Levorsen, A. E., Alemao, E., Yin, D., m, F. B., & Jönsson, L. (2006) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200606020-00006 · Cited by 18
Isma, N., Barani, J., Mattiasson, I., Lindblad, B., & Gottsäter, A. (2008) · Angiology · doi:10.1177/0003319707306144 · Cited by 18
Zachariadou, T., Stoffers, J., Christophi, C. A., Philalithis, A., & Lionis, C. D. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-148 · Cited by 18
Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
Betteridge, J. (2005) · American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.013 · Cited by 19
Harting, J., van Assema, P., van Limpt, P., Gorgels, T., van Ree, J. W., Ruland, E., Vermeer, F., & de Vries, N. K. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.06.016 · Cited by 18
Nilsson, P. M., Cederholm, J., Guðbjörnsdóttir, S., & Eliasson, B. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000188733.60345.78 · Cited by 17
Imaging of coronary atherosclerosis using computed tomography: Current status and future directions
Achenbach, S. S., & Daniel, W. G. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0034-5 · Cited by 18
van der Harst, P., Volbeda, M., Voors, A. A., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000147823.50497.a9 · Cited by 18
Makino, K., Lee, S., Bae, S., Chiba, I., Harada, K., Katayama, O., Shinkai, Y., & Shimada, H. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022004 · Cited by 18
Weeke, P. E., Andersson, C., Fosbøl, E. L., Brendorp, B., Køber, L., Sharma, A. M., Finer, N., James, P., Caterson, I. D., Rode, R. A., et al. (2010) · BMC Endocrine Disorders · doi:10.1186/1472-6823-10-3 · Cited by 16
Mixed dyslipidemias in primary care patients in France
Ambegaonkar, B. M., LaForest, Souchet, Sazonov, & Ganse, E. H. V. (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s27668 · Cited by 16
Assessing coronary heart disease in women
Rollini, F., Mfeukeu, L. K., & Modena, M. G. (2009) · Maturitas · doi:10.1016/j.maturitas.2008.12.013 · Cited by 17
Dysphagia and Obstructive Sleep Apnea in Acute, First-Ever, Ischemic Stroke
Losurdo, A., Brunetti, V., Broccolini, A., Caliandro, P., Frisullo, G., Roberta Morosetti, A., Pilato, F., Profice, P., Giannantoni, N. M., Sacchetti, M. L., et al. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.09.051 · Cited by 17
Li, M., Chadda, K. R., Matthews, G. D. K., Marr, C. M., Huang, C. L.-H., & Jeevaratnam, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194008 · Cited by 18
Body mass index in adults with congenital heart disease
Zaqout, M., Vandekerckhove, K., Michels, N., Demulier, L., Bové, T., François, K., Backer, J. F. A. D., Henauw, S. D., & Wolf, D. D. (2019) · Congenital Heart Disease · doi:10.1111/chd.12751 · Cited by 17
A Comparison of Four Cardiovascular Risk Assessment Instruments in Saudi Patients
Hasabullah, M. A., Kahtani, F., Balkhoyor, T., et al. (2020) · Cureus · doi:10.7759/cureus.7093 · Cited by 17
Triantafyllias, K., Cavagna, L., Klonowski, A., Drott, U., Fiehn, C., Wendel, S., Bergner, R., de Blasi, M., Voll, R. E., Baulmann, J., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa525 · Cited by 19
Subclinical cardiovascular disease and utility of coronary artery calcium score
Saydam, C. D. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100909 · Cited by 20
Low-fat diets for acquired hypercholesterolaemia
Smart, N. A., Marshall, B. J., Daley, M., Boulos, E., Windus, J. L., Baker, N., & Kwok, N. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007957.pub2 · Cited by 17
Non-Attendance for Health Care: When Rational Beliefs Collide
Buetow, S. (2007) · The Sociological Review · doi:10.1111/j.1467-954x.2007.00723.x · Cited by 17
Inhibitory effect of atorvastatin on AGE-induced HCAEC apoptosis by upregulating HSF-1 protein
Li, Y., Li, J., Cui, L., Lai, Y., Yao, Y., Zhang, Y., Pang, X., Wang, J., & Liu, X. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.03.035 · Cited by 17
Bramlage, P., Schmieder, & Goebel (2012) · Vascular Health and Risk Management · doi:10.2147/vhrm.s29915 · Cited by 17
Should a statin be prescribed to every patient with heart failure?
Tsouli, S. G., Liberopoulos, E. N., Goudevenos, J. A., Mikhailidis, D. P., & Elisaf, M. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9041-2 · Cited by 17
Rodríguez-Roca, G. C., Llisterri, J. L., Barrios, V., Alonso-Moreno, F. J., Banegas, J. R., Lou, S., & Matalí, A. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73694-4 · Cited by 17
Inercia terapéutica en prevención secundaria de enfermedad cardiovascular. Registro FRENA
Roa, L., Monréal, M., Carmona, J. A., Aguilar, E., Coll, R., & Suárez, C. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.07.049 · Cited by 17
Subclinical Carotid Atherosclerosis in Asymptomatic Subjects With Type 2 Diabetes Mellitus
Rubinat, E., Marsal, J. R., Vidal, T., Cebrian, C., Falguera, M., Vilanova, M. B., Betriu, À., Fernández, E., Franch‐Nadal, J., & Mauricio, D. (2015) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000236 · Cited by 17
Neil, H. A. W., Perera, R., Armitage, J., Farmer, A. A., Mant, D., & Durrington, P. N. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01828.x · Cited by 17
Fhärm, E., Cederholm, J., Eliasson, B., Guðbjörnsdóttir, S., & Rolandsson, O. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03425.x · Cited by 17
Aguilera, E., Serra‐Planas, E., Granada, M. L., Alonso, N., Pellitero, S., Pizarro, E., Reverter, J. L., Salinas, I., Soldevila, B., Mauricio, D., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1453 · Cited by 18
Jacobs, N., Evers, S., Ament, A. J. H. A., & Claes, N. (2010) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462309990845 · Cited by 17
Buitrago, F., Cañón-Barroso, L., Herrera, N. D., Muro, E. C., Escobar-Fernández, M., & Serrano-Arias, J. M. (2007) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60126-1 · Cited by 17
Wells, S., Kerr, A., Broadbent, E., et al. (2011) · Journal of Primary Health Care · doi:10.1071/hc11004 · Cited by 17
Lynge, T. H., Nielsen, J. L., Blanche, P., Gislason, G., Torp-Pedersen, C. T., Winkel, B. G., Risgaard, B., & Tfelt‐Hansen, J. (2019) · EP Europace · doi:10.1093/europace/euz022 · Cited by 17
Statin Use Over 65 Years of Age and All‐Cause Mortality: A 10‐Year Follow‐Up of 19 518 People
Eilat‐Tsanani, S., Mor, E., & Schonmann, Y. (2019) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16060 · Cited by 16
Ignoring social factors in clinical decision rules: a contribution to health inequalities?
Lang, T. (2005) · European Journal of Public Health · doi:10.1093/eurpub/cki156 · Cited by 17
Gender-Specific Prediction of Cardiac Disease
D'Amore, S., & Mora, S. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000244460.25429.c8 · Cited by 17
Introduction: Apolipoproteins and guidelines for prevention of cardiovascular disease
Færgeman, O. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01650.x · Cited by 18
Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease
Poussa, H., Strandberg, T. E., Tikkanen, I. T., Kauhanen, P., & Lepäntalo, M. (2007) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430601187751 · Cited by 17
Tonstad, S., Thorsrud, H., Torjesen, P. A., & Seljeflot, I. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.006 · Cited by 17
Self‐Rated Health and Risk Factors for Metabolic Syndrome Among Middle‐Aged Men
Näslindh‐Ylispangar, A., Sihvonen, M., Vanhanen, H. T., & Kekki, P. (2005) · Public Health Nursing · doi:10.1111/j.0737-1209.2005.220607.x · Cited by 17
Croom, K. F., & Plosker, G. L. (2005) · Drugs · doi:10.2165/00003495-200565010-00015 · Cited by 17
Evaluation of lipid metabolism and nutritional status in male goalball players
Gawlik, K., Zwierzchowska, A., & Rosołek, B. (2015) · Journal of Human Kinetics · doi:10.1515/hukin-2015-0100 · Cited by 10
Metadata
- Authors
- De Backer, G.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-09
- Volume
- 24
- Issue
- 17
- Pages
- 1601-1610
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2153788691
- Cited by
- 2,251
- References
- 0
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 15 · 2023: 19 · 2022: 12 · 2021: 55 · 2020: 64 · 2019: 92 · 2018: 65 · 2017: 67 · 2016: 51 · 2015: 57 · 2014: 78 · 2013: 87 · 2012: 98
- FWCI
- 206.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- cardiovascular disease prevention, guideline development methodology, quality of evidence, clinical decision-making, guideline implementation, cardiovascular risk management
- MeSH terms
- Smoking Prevention, Blood Pressure, Cardiovascular Diseases, Diagnostic Imaging, Diet, Europe, Health Priorities, Humans, Lipids, Risk Factors, Exercise, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
